A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 29, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2029

Conditions

Liver Transplantation

Interventions

BIOLOGICAL

TCD601

Investigational Product

BIOLOGICAL

Cyclophosphamide

Conditioning Regimen

DRUG

TAC

Immunosuppression Therapy

DRUG

MMF

Immunosuppression Therapy

DRUG

Corticosteroids

Immunosuppression Therapy

Trial Locations (1)

Karolinska University Hospital, Stockholm

All Listed Sponsors

lead

ITB-Med LLC

INDUSTRY